Commonly used gastrointestinal drugs

Handbook of Clinical Neurology

Volumn 120, Issue , 2014, Pages 633-643

  Aggarwal, Annu ^a   Bhatt, Mohit ^a  

^a Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute   (India)

Author keywords

Acute dystonia; Drug induced parkinsonism; Extrapyramidal; Gastrointestinal drugs; Hyperthermic syndromes; Levosulpiride; Metoclopramide; Neurotoxicity; Phenothiazines; Proton pump inhibitors; Selective histamine blockers; Setrons; Tardive dyskinesias

Indexed keywords

GASTROINTESTINAL AGENT; METOCLOPRAMIDE; PHENOTHIAZINE DERIVATIVE; PROTON PUMP INHIBITOR; SULPIRIDE;

ACUTE DYSTONIA; ARTICLE; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; DRUG-INDUCED PARKINSONISM; EXTRAPYRAMIDAL; GASTROINTESTINAL DRUGS; HUMAN; HYPERTHERMIC SYNDROMES; NEUROLOGIC DISEASE; NEUROTOXICITY; SELECTIVE HISTAMINE BLOCKERS; SETRONS; TARDIVE DYSKINESIAS;

ACUTE DYSTONIA; DRUG-INDUCED PARKINSONISM; EXTRAPYRAMIDAL; GASTROINTESTINAL DRUGS; HYPERTHERMIC SYNDROMES; LEVOSULPIRIDE; METOCLOPRAMIDE; NEUROTOXICITY; PHENOTHIAZINES; PROTON PUMP INHIBITORS; SELECTIVE HISTAMINE BLOCKERS; SETRONS; TARDIVE DYSKINESIAS;

GASTROINTESTINAL AGENTS; HUMANS; NERVOUS SYSTEM DISEASES;

EID: 84890849639     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-7020-4087-0.00043-7     Document Type: Chapter

References (137)

1. Aapro M.S., Walko C.M. Aprepitant: drug-drug interactions in perspective. Ann Oncol 2010, 21:2316-2323.
2. Andrejak M., Masmoudi K., Mizon J.P. Acute dyskinesia after the ingestion of antiemetics leading to emergency hospitalization. Therapie 1990, 45:33-35.
3. Anfinson T.J. Akathisia, panic, agoraphobia, and major depression following brief exposure to metoclopramide. Psychopharmacol Bull 2002, 36:82-93.
4. Baik J.S., Lyoo C.H., Lee J.H., et al. Drug-induced and psychogenic resting suprahyoid neck and tongue tremors. Mov Disord 2008, 23:746-748.
5. Bateman D.N., Gokal R. Metoclopramide in renal failure. Lancet 1980, 1:982.
6. Bateman D.N., Kahn C., Mashiter K., et al. Pharmacokinetic and concentration-effect studies with intravenous metoclopramide. Br J Clin Pharmacol 1978, 6:401-407.
7. Bateman D.N., Rawlins M.D., Simpson J.M. Extrapyramidal reactions with metoclopramide. Br Med J (Clin Res Ed) 1985, 291:930-932.
8. Bateman D.N., Darling W.M., Boys R., et al. Extrapyramidal reactions to metoclopramide and prochlorperazine. Q J Med 1989, 71:307-311.
9. Bhanji N.H., Margolese H.C. Extrapyramidal symptoms related to adjunctive nizatidine therapy in an adolescent receiving quetiapine and paroxetine. Pharmacotherapy 2004, 24:923-925.
10. Bhatt M., Sethi K., Bhatia K. Acute and tardive dystonia. Drug-Induced Movement Disorders 2004, 111-128. Marcel Dekker, New York. K. Sethi (Ed.).
11. Biasini A., Alberti A. Extrapyramidal dysfunction after domperidone. Helv Paediatr Acta 1985, 40:93-94.
12. Bondon-Guitton E., Perez-Lloret S., Bagheri H., et al. Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France. Mov Disord 2011, 26:2226-2231.
13. Bories P., Michel H., Brigitte D., et al. Use of ranitidine, without mental confusion, in patient with renal failure. Lancet 1980, 2:755.
14. Boyer E.W., Shannon M. The serotonin syndrome. N Engl J Med 2005, 352:1112-1120.
15. Burke R.E., Kang U.J., Jankovic J., et al. Tardive akathisia: an analysis of clinical features and response to open therapeutic trials. Mov Disord 1989, 4:157-175.
16. Burns R., Thomas D.W., Barron V.J. Reversible encephalopathy possibly associated with bismuth subgallate ingestion. Br Med J 1974, 1:220-223.
17. Caldwell C., Rains G., McKiterick K. An unusual reaction to preoperative metoclopramide. Anesthesiology 1987, 67:854-855.
18. Casteels-Van Daele M., Jaeken J., Van der Schueren P., et al. Dystonic reactions in children caused by metoclopramide. Arch Dis Child 1970, 45:130-133.
19. Catalano G., Catalano M.C., Alberts V.A. Famotidine-associated delirium. A series of six cases. Psychosomatics 1996, 37:349-355.
20. Cerra B.F., Schentag J.J., Mcmillen M., et al. Mental status, the intensive care unit and cimetidine. Ann Surg 1982, 196:565-570.
21. Chow L.Y., Chung D., Leung V., et al. Suicide attempt due to metoclopramide-induced akathisia. Int J Clin Pract 1997, 51:330-331.
22. Costall B., Naylor R.J. Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect?. Psychopharmacologia 1973, 32:161-170.
23. Critchley P., Langdon N., Parkes J.D., et al. Domperidone. Br Med J (Clin Res Ed) 1985, 290:788.
24. Cundy T., Dissanayake A. Severe hypomagnesaemia in long-term users of proton-pump inhibitors. Clin Endocrinol (Oxf) 2008, 69:338-341.
25. Davis W.A. Mental confusion associated with ranitidine. Med J Aust 1984, 140:478.
26. Dieckmann K., Maurage C., Rolland J.C., et al. Torticollis as a side effect of cisapride treatment in an infant. J Pediatr Gastroenterol Nutr 1996, 22:336.
27. Dobrow R.B., Coppock M.A., Hosenpud J.R. Extrapyramidal reaction caused by ondansetron. J Clin Oncol 1991, 9:1921.
28. Drake R.E., Ehrlich J. Suicide attempts associated with akathisia. Am J Psychiatry 1985, 142:499-501.
29. Duncan M.A., Nikolov N.M., O'Kelly B. Acute chorea due to ondansetron in an obstetric patient. Int J Obstet Anesth 2001, 10:309-311.
30. Edmonds M.E., Ashford R.F., Brenner M.K., et al. Cimetidine: does neurotoxicity occur?. J R Soc Med 1979, 72:172.
31. Ellis G.L., Delaney J., DeHart D.A., et al. The efficacy of metoclopramide in the treatment of migraine headache. Ann Emerg Med 1993, 22:191-195.
32. Elzinga-Huttenga J., Hekster Y., Bijl A., et al. Movement disorders induced by gastrointestinal drugs: two paediatric cases. Neuropediatrics 2006, 37:102-106.
33. Escourelle R., Bourdon R., Galli A., et al. Neuropathologic and toxicologic study of 12 cases of bismuth encephalopathy. Rev Neurol 1977, 133:153-163.
34. Feest T.G., Read D.J. Myopathy associated with cimetidine?. Br Med J 1980, 281:1284-1285.
35. Feyer P., Jordan K. Update and new trends in antiemetic therapy: the continuing need for novel therapies. Ann Oncol 2011, 22:30-38.
36. Fisher A.A., Davis M.W. Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction. Ann Pharmacother 2002, 36:67-71.
37. Flind A.C., Rowley-Jones D. Mental confusion and cimetidine. Lancet 1979, 1:379.
38. Ford A.C., Malfertheiner P., Giguere M., et al. Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis. World J Gastroenterol 2008, 14:7361-7370.
39. Fouddah A., Canivet J.L., Damas P. Clinical case of the month. Severe dyskinetic syndrome induced by ranitidine. Rev Med Liege 2001, 56:548-551.
40. Franckx J., Noel P. Acute extrapyramidal dysfunction after domperidone administration. Report of a case. Helv Paediatr Acta 1984, 39:285-288.
41. Galynker I.I., Tendler D.S. Nizatidine-induced delirium in a nonagenarian. J Clin Psychiatry 1997, 58:327.
42. Ganzini L., Casey D.E., Hoffman W.F., et al. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med 1993, 153:1469-1475.
43. Gatrad A.R., Gatrad A.H. Familial incidence of dystonic reactions to metoclopramide (Maxolon). Br J Clin Pract 1979, 33:111-115.
44. George M., Al-Duaij N., O'Donnell K.A., et al. Obtundation and seizure following ondansetron overdose in an infant. Clin Toxicol 2008, 46:1064-1066.
45. Gralla R.J., Itri L.M., Pisko S.E., et al. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 1981, 305:905-909.
46. Grimes J.D. Parkinsonism and tardive dyskinesia associated with long-term metoclopramide therapy. N Engl J Med 1981, 305:1417.
47. Grimes J.D., Hassan M.N., Krelina M. Long-term follow-up of tardive dyskinesia due to metoclopramide. Lancet 1982, 4:563.
48. Grimes J.D., Hassan M.N., Preston D.N. Adverse neurologic effects of metoclopramide. Can Med Assoc J 1982, 126:23-25.
49. Grundy D., Al-Chaer E.D., Aziz Q., et al. Fundamentals of neurogastroenterology: basic science. Gastroenterology 2006, 130:1391-1411.
50. Guala A., Mittino D., Fabbrocini P., et al. Familial metoclopramide-induced dystonic reactions. Mov Disord 1992, 7:385-386.
51. Guzé B.H., Baxter L.R. Current concepts. Neuroleptic malignant syndrome. N Engl J Med 1985, 313:163-166.
52. Handler C.E., Besse C.P., Wilson A.O. Extrapyramidal and cerebellar syndrome with encephalopathy associated with cimetidine. Postgrad Med J 1982, 58:527-528.
53. Harrington R.A., Hamilton C.W., Brogden R.N., et al. Metoclopramide. An updated review of its pharmacological properties and clinical use. Drugs 1983, 25:451-494.
54. Henann N.E., Carpenter D.U., Janda S.M. Famotidine-associated mental confusion in elderly patients. Drug Intell Clin Pharm 1988, 22:976-978.
55. Herbert M.K., Holzer P. Standardized concept for the treatment of gastrointestinal dysmotility in critically ill patients - current status and future options. Clin Nutr 2008, 27:25-41.
56. Herrstedt J. Antiemetics: an update and the MASCC guidelines applied in clinical practice. Nat Clin Pract Oncol 2008, 5:32-43.
57. Herrstedt J., Dombernowsky P. Anti-emetic therapy in cancer chemotherapy: current status. Basic Clin Pharmacol Toxicol 2007, 101:143-150.
58. Hesketh P.J. Chemotherapy-induced nausea and vomiting. N Engl J Med 2008, 358:2482-2494.
59. Howden C.W., Tytgat G.N. The tolerability and safety profile of famotidine. Clin Ther 1996, 18:36-54.
60. Hughes J.D., Reed W.D., Serjeant C.S. Mental confusion associated with ranitidine. Med J Aust 1983, 2:12-13.
61. Indo T., Ando K. Metoclopramide-induced Parkinsonism. Clinical characteristics of ten cases. Arch Neurol 1982, 39:494-496.
62. Kanarek B.B., Curnow R., Palmer J., et al. Ondansetron: confusing documentation surrounding an extrapyramidal reaction. J Clin Oncol 1992, 10:506-507.
63. Karamanolis G., Tack J. Promotility medications - now and in the future. Dig Dis 2006, 24:297-307.
64. Kenney C., Hunter C., Davidson A., et al. Metoclopramide, an increasingly recognized cause of tardive dyskinesia. J Clin Pharmacol 2008, 48:379-384.
65. Kerr G.W. Dystonic reactions: two case reports. J Accid Emerg Med 1996, 13:221-222.
66. Kim J.S., Ko S.B., Han S.R., et al. Levosulpiride-induced Parkinsonism. J Korean Neurol Assoc 2003, 21:418-421.
67. Kounenis G., Koutsoviti-Papadopoulou, Elezoglou V. Effect of nizatidine and ranitidine on the D-tubocurarine neuromuscular blockade in the toad rectus abdominis muscle. Pharmacol Res 1994, 29:155-161.
68. Kovac A.L. Benefits and risks of newer treatments for chemotherapy-induced and postoperative nausea and vomiting. Drug Saf 2003, 26:227-259.
69. Kumar N., Hu W.T. Extrapyramidal reaction to ondansetron and propofol. Mov Disord 2009, 24:312-313.
70. LaGorio J., Thompson V.A., Sternberg D., et al. Akathisia and anesthesia: refusal of surgery after the administration of metoclopramide. Anesth Analg 1998, 87:224-227.
71. Lang A.E. Akathisia and restless leg syndrome. Parkinson's Disease and Movement Disorders 1988, 349-364. Urban and Schwarzenberg, Baltimore. J. Jankovic, E. Tolosa (Eds.).
72. Lavy S., Melamed E., Penchas S. Tardive dyskinesia associated with metoclopramide. Br Med J 1978, 1:77-78.
73. Lee C.R., Plosker G.L., McTavish D. Tropisetron. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as an antiemetic. Drugs 1993, 46:925-943.
74. Lee C.Y., Ratnapalan S., Thompson M., et al. Unusual reactions to 5-HT3 receptor antagonists in a child with rhabdomyosarcoma. Can J Clin Pharmacol 2010, 17:1-4.
75. Leeser J., Bateman D.N. Domperidone. Br Med J (Clin Res Ed) 1985, 290:241-242.
76. Leo R.J., Lichter D.G., Hershey L.A. Parkinsonism associated with fluoxetine and cimetidine: a case report. J Geriatr Psychiatry Neurol 1995, 8:231-233.
77. Lewis J.H. Safety profile of long-term H2-antagonist therapy. Aliment Pharmacol Ther 1991, 5:49-57.
78. Lu C.S., Chu N.S. Acute dystonic reaction with asterixis and myoclonus following metoclopramide therapy. J Neurol Neurosurg Psychiatry 1988, 51:1002-1003.
79. Lucena R., Monteiro L., Melo A. Cisapride related movement disorders. J Pediatr 1998, 74:416-418.
80. Mark R., Newton-John H. Acute upper airway obstruction due to supraglottic dystonia induced by a neuroleptic. Br Med J 1988, 297:964-965.
81. Mastaglia F.L., Argov Z. Toxic and iatrogenic myopathies. Handb Clin Neurol 2007, 86:321-341.
82. Miller L.G., Jankovic J. Metoclopramide-induced movement disorders. Clinical findings with a review of the literature. Arch Intern Med 1989, 149:2486-2492.
83. Morrow A.W. Requests for reports; adverse reactions with bismuth subgallate. Med J Aust 1973, 1:912.
84. Naito Y., Kuzuhara S. Parkinsonism induced or worsened by cisapride. Nihon Ronen Igakkai Zasshi 1994, 31:899-902.
85. Nampiaparampil D., Oruc N.E. Metodopramide-induced palatopharyngeal myoclonus. Mov Disord 2006, 21:2028-2029.
86. Parikh N., Howden C.W. The safety of drugs used in acid-related disorders and functional gastrointestinal disorders. Gastroenterol Clin North Am 2010, 39:529-542.
87. Parkman H.P., Hasler W.L., Fisher R.S., et al. American Gastroenterology Association review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004, 127:1592-1622.
88. Parlak I., Atilla R., Cicek M., et al. Rate of metoclopramide infusion affects the severity and incidence of akathisia. Emerg Med J 2005, 22:621-624.
89. Pasricha P.J. Desperately seeking serotonin. A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders. Gastroenterology 2007, 132:2287-2290.
90. Pasricha P.J., Pehlivanov N., Sugumar A., et al. Drug insight: from disturbed motility to disordered movement - a review of the clinical benefits and medicolegal risks of metoclopramide. Nat Clin Pract Gastroenterol Hepatol 2006, 3:138-148.
91. Patel A., Mittal S., Manchanda S., et al. Ondansetron-induced dystonia, hypoglycemia, and seizures in a child. Ann Pharmacother 2011, 45:7.
92. Peiris R.S., Peckler B.F. Cimetidine-induced dystonic reaction. J Emerg Med 2001, 21:27-29.
93. Perez-Lloret S., Bondon-Guitton E., Rascol O., et al. Adverse drug reactions to dopamine agonists: a comparative study in the French Pharmacovigilance Database; French Association of Regional Pharmacovigilance Centers. Mov Disord 2010, 25:1876-1880.
94. Poortinga E., Rosenthal D., Bagri S. Metoclopramide-induced akathisia during the second trimester of a 37-year-old woman's first pregnancy. Psychosomatics 2001, 42:153-156.
95. Raschetti R., Maggini M., Da Cas R., et al. Time trends in the coprescribing of cisapride and contraindicated drugs in Umbria, Italy. JAMA 2001, 285:1840-1841.
96. Reid M. Dystonic reactions to metoclopramide (Maxolon). Ulster Med J 1977, 46:38-40.
97. Ritter M.J., Goodman B.P., Sprung J., et al. Ondansetron-induced multifocal encephalopathy. Mayo Clin Proc 2003, 78:1150-1152.
98. Robinson O.P. Metoclopramide - side effects and safety. Postgrad Med J 1973, 49:77-80.
99. Rodgers P.T., Brengel G.R. Famotidine-associated mental status changes. Pharmacotherapy 1998, 18:404-407.
100. Roila F., Fatigoni S. New antiemetic drugs. Ann Oncol 2006, 2:ii96-ii100.
101. Rossi F., Forgione A. Pharmacotoxicological aspects of levosulpiride. Pharmacol Res 1995, 31:81-94.
102. Roy-Desruisseaux J., Landry J., Bocti C., et al. Domperidone-induced tardive dyskinesia and withdrawal psychosis in an elderly woman with dementia. Ann Pharmacother 2011, 45:51.
103. Sachdev P., Kruk J. Clinical characteristics and predisposing factors in acute drug-induced akathisia. Arch Gen Psychiatry 1994, 51:963-974.
104. Samie M.R., Dannenhoffer M.A., Rozek S. Life-threatening tardive dyskinesia caused by metoclopramide. Mov Disord 1987, 2:125-129.
105. Sargent A.I., Deppe S.A., Chan F.A. Seizure associated with ondansetron. Clin Pharmacol 1993, 12:613-615.
106. Schneider S.A., Udani V., Sankhla C.S., et al. Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs. Mov Disord 2009, 24:1226-1229.
107. Schulze-Delrieu K. Drug therapy. Metoclopramide. N Engl J Med 1981, 305:28-33.
108. Sethi K.D. Drug-Induced Movement Disorders 2004, Marcel Dekker, New York.
109. Sewell D.D., Jeste D.V. Metoclopramide-associated tardive dyskinesia. An analysis of 67 cases. Arch Fam Med 1992, 1:271-278.
110. Shaffer D., Butterfield M., Pamer C., et al. Tardive dyskinesia risks and metoclopramide use before and after U.S. market withdrawal of cisapride. J Am Pharm Assoc 2004, 44:661-665.
111. Sharma A., Raina V. Generalized seizures following ondansetron. Ann Oncol 2001, 12:131-132.
112. Sharpe P.C., Burland W.L. Mental confusion and H2-receptor blockers. Lancet 1980, 2:924.
113. Shin H.W., Kim M.J., Kim J.S., et al. Levosulpiride-induced movement disorders. Mov Disord 2009, 24:2249-2253.
114. Sills J.A., Glass E.J. Metoclopramide in young children. Br Med J 1978, 2:431.
115. Silverstone P.H. Ranitidine and confusion. Lancet 1984, 1:1071.
116. Singh N.N., Rai A., Selhorst J.B., et al. Ondansetron and seizures. Epilepsia 2009, 50:2663-2666.
117. Sorbe B., Hallén C., Frankendal B. An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis. Cancer Chemother Pharmacol 1994, 33:298-302.
118. Spiegel J.E., Kang V., Kunze L., et al. Ondansetron-induced extrapyramidal symptoms during cesarean section. Int J Obstet Anesth 2005, 14:368-369.
119. Sprung J., Choudhry F.M., Hall B.A. Extrapyramidal reactions to ondansetron: cross-reactivity between ondansetron and prochlorperazine?. Anesth Analg 2003, 96:1374-1376.
120. Stacy M., Jankovic J. Tardive tremor. Mov Disord 1992, 7:53-57.
121. Steinherz R., Levy Y., Ban-Amiti D., et al. Extrapyramidal reactions to domperidone. J Pediatr 1986, 108:630-631.
122. Stonell C. An extrapyramidal reaction to ondansetron. Br J Anaesth 1998, 81:658.
123. Supino-Viterbo V., Sicard C., Risvegliato M., et al. Toxic encephalopathy due to ingestion of bismuth salts: clinical and EEG studies of 45 patients. J Neurol Neurosurg Psychiatry 1977, 40:748-752.
124. Tarsy D., Indorf G. Tardive tremor due to metoclopramide. Mov Disord 2002, 17:620-621.
125. Tillman L.A., Drake F.M., Dixon J.S., et al. Review article: safety of bismuth in the treatment of gastrointestinal diseases. Aliment Pharmacol Ther 1996, 10:459-467.
126. Tisdale S.A. Metoclopramide. N Engl J Med 1981, 305:1093.
127. Toga T., Kohmura Y., Kawatsu R. The 5-HT(4) agonists cisapride, mosapride, and CJ-033466, a novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)-blocking activities. J Pharmacol Sci 2007, 105:207-210.
128. Tolan M.M., Fuhrman T.M., Tsueda K., et al. Perioperative extrapyramidal reactions associated with ondansetron. Anesthesiology 1999, 90:340-341.
129. Van der Padt A., Van Schaik R.H., Sonneveld P. Acute dystonic reaction to metoclopramide in patients carrying homozygous cytochrome P450 2D6 genetic polymorphisms. Neth J Med 2006, 64:160-162.
130. Vandenplas Y., Benatar A., Cools F., et al. Efficacy and tolerability of cisapride in children. Paediatr Drugs 2001, 3:559-573.
131. Walls T.J., Pearce S.J., Venables G.S. Motor neuropathy associated with cimetidine. Br Med J 1980, 281:974-975.
132. Weaving A., Bezwoda W.R., Derman D.P. Seizures after antiemetic treatment with high dose domperidone: report of four cases. Br Med J (Clin Res Ed) 1984, 288:1728.
133. Weiden P.J., Mann J.J., Haas G., et al. Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study. Am J Psychiatry 1987, 144:1148-1153.
134. Wilson L.B., Woodward A.M., Ferrara J.J. An acute dystonic reaction with long-term use of ranitidine in an intensive care unit patient. J La State Med Soc 1997, 149:36-38.
135. Yamamoto M., Ujike H., Ogawa N. Metoclopramide-induced parkinsonism. Clin Neuropharmacol 1987, 10:287-289.
136. Yuan R.Y., Kao C.R., Sheu J.J., et al. Delirium following a switch from cimetidine to famotidine. Ann Pharmacother 2001, 35:1045-1048.
137. Zambelli A., Sagrada P., Pavesi L. Seizure associated with palonosetron. Support Care Cancer 2009, 17:217.